Reinhard Kirnbauer focuses on Virology, Molecular biology, Antibody, Papillomaviridae and Bovine papillomavirus. The various areas that Reinhard Kirnbauer examines in his Virology study include Epitope and Immunology. Reinhard Kirnbauer has researched Epitope in several fields, including Virus and Virus-like particle.
The concepts of his Molecular biology study are interwoven with issues in Cell culture, Keratinocyte, Cytokine, Capsid and Cytotoxic T cell. Antibody and Adjuvant are commonly linked in his work. His study explores the link between Bovine papillomavirus and topics such as Immunization that cross with problems in Immunoglobulin G.
Virology, Immunology, Antibody, Epitope and Molecular biology are his primary areas of study. Virology is closely attributed to Bovine papillomavirus in his research. His work in Bovine papillomavirus addresses issues such as Papillomaviridae, which are connected to fields such as Hemagglutination.
His study in Antibody is interdisciplinary in nature, drawing from both In vitro, Virus-like particle and Immune system. His Epitope research is multidisciplinary, relying on both Monoclonal antibody, Immunogenicity and Pseudovirion. Reinhard Kirnbauer combines subjects such as Infectivity, Cell culture, Antiserum and Cytokine with his study of Molecular biology.
His primary scientific interests are in Virology, Antibody, Immunology, Vaccination and Epitope. His Virology research integrates issues from Chimeric virus and Immunogenicity. His Antibody research includes themes of In vitro and Virus-like particle.
His biological study spans a wide range of topics, including Bovine papillomavirus and Disease. His Vaccination study incorporates themes from Virus and Pseudovirion. Reinhard Kirnbauer focuses mostly in the field of Epitope, narrowing it down to matters related to Capsid and, in some cases, Cell culture and Sf9.
Reinhard Kirnbauer mainly investigates Virology, Antibody, Papillomavirus Vaccines, Epitope and Vaccination. His research in Virology intersects with topics in HPV infection and Immunology, Antigen, Immunogenicity. His HPV infection research includes elements of Papillomaviridae, Saliva and Immunoglobulin G.
The concepts of his Antigen study are interwoven with issues in Cervical cancer, Virus-like particle, Fusion protein and Pseudovirion. His work in Immunogenicity covers topics such as Adjuvant which are related to areas like Titer, Serotype, Heterologous, Immune system and Bovine papillomavirus. His studies deal with areas such as Neutralization and Capsid as well as In vitro.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
R Kirnbauer;F Booy;N Cheng;D R Lowy.
Proceedings of the National Academy of Sciences of the United States of America (1992)
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.
A Köck;T Schwarz;R Kirnbauer;A Urbanski.
Journal of Experimental Medicine (1990)
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.
Reinhard Kirnbauer;Janet Taub;Heather Greenstone;Richard Roden.
Journal of Virology (1993)
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.
F Breitburd;R Kirnbauer;N L Hubbert;B Nonnenmacher.
Journal of Virology (1995)
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
Heather L. Greenstone;John D. Nieland;Karin E. de Visser;Marloes L. H. De Bruijn.
Proceedings of the National Academy of Sciences of the United States of America (1998)
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
Reinhard Kirnbauer;Nancy L. Hubbert;Cosette M. Wheeler;Thomas M. Becker.
Journal of the National Cancer Institute (1994)
Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic Immunization
R. Kirnbauer;L.M. Chandrachud;B.W. O'neil;E.R. Wagner.
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
Richard B.S. Roden;Heather L. Greenstone;Reinhard Kirnbauer;Frank P. Booy.
Journal of Virology (1996)
Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.
Saeed Shafti-Keramat;Alessandra Handisurya;Ernst Kriehuber;Guerrino Meneguzzi.
Journal of Virology (2003)
Ultraviolet light induces increased circulating interleukin-6 in humans.
Agatha Urbanski;Thomas Schwarz;Peter Neuner;Jean Krutmann.
Journal of Investigative Dermatology (1990)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: